CAPTRUST Financial Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,600
Closed -$12K 3467
2022
Q2
$12K Sell
8,600
-57
-0.7% -$85 ﹤0.01% 3660
2022
Q1
$18K Sell
8,657
-95
-1% -$231 ﹤0.01% 3459
2021
Q4
$32K Buy
8,752
+178
+2% +$766 ﹤0.01% 2983
2021
Q3
$43K Sell
8,574
-22
-0.3% -$127 ﹤0.01% 2677
2021
Q2
$56K Buy
8,596
+1,350
+19% +$9.43K ﹤0.01% 2445
2021
Q1
$50K Buy
+7,246
New +$61.3K ﹤0.01% 2431
2020
Q3
Sell
-57
Closed 3180
2020
Q2
$0 Buy
+57
New +$194 ﹤0.01% 2879
2019
Q4
Sell
-289
Closed -$2K 1571
2019
Q3
$2K Buy
289
+232
+407% +$1.58K ﹤0.01% 1803
2019
Q2
$0 Hold
57
﹤0.01% 1983
2019
Q1
$0 Hold
57
﹤0.01% 1872
2018
Q4
$0 Sell
57
-300
-84% -$3.36K ﹤0.01% 1648
2018
Q3
$6K Buy
+357
New +$5.31K ﹤0.01% 1334

Other funds holding PGEN

CAPTRUST Financial Advisors's PGEN Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Precigen (PGEN) in Q3 2022, closing a stake of 8,600 shares — an estimated $12K sold.

CAPTRUST Financial Advisors first reported a position in PGEN in Q3 2018 and held it in 12 quarters. The position peaked at $56K in Q2 2021. 165 funds tracked by Wall St. Rank hold PGEN as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Precigen position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 8,600 Precigen shares in Q3 2022, an estimated $12K.
  • CAPTRUST Financial Advisors first reported a position in Precigen in Q3 2018 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's Precigen position peaked at $56K in Q2 2021.
  • 165 funds tracked by Wall St. Rank held Precigen as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.